Results 71 to 80 of about 89,329 (283)
ABSTRACT Background Preirradiated patients undergoing microvascular head and neck reconstruction for tumor recurrence or osteoradionecrosis (ORN) face surgical site infection (SSI) rates exceeding 30%. The impact of perioperative extended‐spectrum antibiotic coverage remains unclear. This study hypothesizes that calculated prophylaxis with piperacillin/
Johannes G. Schuderer +11 more
wiley +1 more source
Background Lipid metabolism is a key regulator of inflammation in acute and chronic conditions. However, whether dyslipidemia is related to the process of osteomyelitis remains unclear.
Zhiyi Zhou +8 more
doaj +1 more source
Case Report of Post-Appendectomy Fungal Osteomyelitis: A Rare Complication in a Healthy Patient
Introduction: Osteomyelitis is a bone infection that presents with swelling, erythema, pain, and possible systemic symptoms. Immunocompromised patients are at higher risk of developing osteomyelitis.
Cameron Juybari +3 more
doaj +1 more source
Garre’s osteomyelitis of the mandible managed by nonsurgical re-endodontic treatment [PDF]
Chronic osteomyelitis with proliferative periostitis, known as Garre’s osteomyelitis, is a type of osteomyelitis characterized by a distinctive gross thickening of the periosteum of bones.
Heegyun Kim +5 more
doaj +1 more source
Osteomyelitis of Maxilla: A Rare Presentation Yet Not So Rare
Jeevan Lata, Neetu Pansotra
openalex +2 more sources
ABSTRACT Objective To evaluate oncological outcomes and their predictors following salvage oropharyngectomy. Methods This single‐center retrospective study included patients who underwent a salvage oropharyngectomy in an irradiated neck for recurrent or metachronous oropharyngeal squamous cell carcinoma (OPSCC) between 2014 and 2023.
Jade Saykaly +8 more
wiley +1 more source
Preliminary image evaluation (PIE) comment errors were evaluated for common errors. These include missed avulsion fractures in the finger, hand, and wrist, while accessory bones in the feet and ankle were mistaken for abnormalities. Identifying these errors provides guidance for ongoing, regular, targeted training to help improve PIE accuracy rates ...
Kim Lewis +3 more
wiley +1 more source
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo +11 more
wiley +1 more source
Antibiotic-Loaded Resorbable Bone-Graft Substitute: A New Treatment for Osteomyelitis/Osteitis [PDF]
Bernd Gächter +4 more
openalex +1 more source
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson +12 more
wiley +1 more source

